Our mission is to address significant unmet medical needs in respiratory and pulmonary diseases for both pediatric and adult populations by developing novel combination therapies with a focus on RSV and other antiviral, anti-fibrotic, and anti-inflammatory agents. Leveraging our expertise in pediatric drug development, we are committed to developing novel therapeutics that are first-in-class or potentially best-in-class.
We strive for scientific excellence and continuous innovation, with a focus on drug discovery and development for pediatrics, respiratory and lung diseases; We aspire to become a global leader in the research and development of innovative drugs in these specialty pharmaceutical fields; We endeavor to create a supportive and rewarding work environment for our employees, to generate favorable return for our investors and partners, and to return for the benefits of our community and society.
Ark's core values reflect our unwavering belief in achieving the vision to build a science-driven biopharmaceutical company: Integrity and Dedication, Professionalism and Motivation, Science and Innovation, Collaboration and Sharing.
  • Home
  • Tel
  • Top